Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)
Clinical trial NCT00424554 · COMPLETED
Trial details
- NCT number
- NCT00424554
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-26
- Primary completion
- 2010-01-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.